VJHemOnc is committed to improving our service to you

CAR-T Meeting 2020 | Regulation helps deliver CAR T-cell therapy efficiently

VJHemOnc is committed to improving our service to you

Ulrich Jäger

Here, Ulrich Jäger, MD, Medical University of Vienna, Vienna, Austria, outlines the importance of regulation when a novel therapy such as CAR T-cell therapy is introduced, and what to expect from the regulatory session taking place on Day 2 of the 2nd European CAR T-cell Meeting in Sitges, Spain.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter